Regenerative Medical Technology (RMTG) Assets Average (2019 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Assets Average of $4.7 million for Q1 2026, up 21.74% year-over-year from $3.9 million in Q1 2025, and up 5.44% quarter-over-quarter from $4.5 million in Q4 2025.
Regenerative Medical Technology (RMTG) Assets Average (2019 - 2026) Analysis & Trends
Regenerative Medical Technology's Assets Average history runs 8 years deep, the most recent figure standing at $4.7 million for Q1 2026.
- In Q1 2026, Assets Average rose 21.74% year-over-year to $4.7 million; the TTM figure through Mar 2026 stood at $4.7 million (up 21.74% YoY), while the FY2025 annual figure was $4.2 million, up 24.02% from the prior year.
- Assets Average for Q1 2026 stood at $4.7 million, up from $4.5 million in the prior quarter.
- The five-year high for Assets Average was $9.1 million in Q1 2022, with the low at $3.0 million in Q1 2024.
- The 5-year median for Assets Average is $4.5 million (2025), against an average of $5.5 million.
- The sharpest annual moves came in 2022 and 2024: Assets Average jumped 1441.91% in 2022, then plunged 63.1% in 2024.
- Regenerative Medical Technology's Assets Average stood at $8.2 million in 2022, then plunged by 62.03% to $3.1 million in 2023, then rose by 13.82% to $3.5 million in 2024, then increased by 27.79% to $4.5 million in 2025, then gained by 5.44% to $4.7 million in 2026.
- Business Quant data shows RMTG's Assets Average at $4.7 million in Q1 2026, $4.5 million in Q4 2025, and $4.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.47 Bn | 131.61 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.36 Bn | 78.37 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.99 Bn | 53.85 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.74 Bn | 28.43 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.01 Bn | 9.61 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 19.82 Bn |
| 10 | Regenerative Medical Technology | 829,068.92 | -232,379.08 | 1.77 Mn | 4.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.75 Mn |
| Dec 31, 2025 | 4.50 Mn |
| Sep 30, 2025 | 4.50 Mn |
| Jun 30, 2025 | 4.23 Mn |
| Mar 31, 2025 | 3.90 Mn |
| Dec 31, 2024 | 3.52 Mn |
| Sep 30, 2024 | 3.14 Mn |
| Jun 30, 2024 | 3.06 Mn |
| Mar 31, 2024 | 2.98 Mn |
| Dec 31, 2023 | 3.10 Mn |
| Sep 30, 2023 | 5.43 Mn |
| Jun 30, 2023 | 7.80 Mn |
| Mar 31, 2023 | 8.07 Mn |
| Dec 31, 2022 | 8.16 Mn |
| Sep 30, 2022 | 8.30 Mn |
| Jun 30, 2022 | 8.66 Mn |
| Mar 31, 2022 | 9.13 Mn |
| Dec 31, 2021 | 13.19 Mn |
| Sep 30, 2021 | 13.99 Mn |
| Jun 30, 2021 | 5.94 Mn |